# ClinicalTrials.gov record NCT06893211

> PeptideScanner retained ClinicalTrials.gov record NCT06893211 at 2026-08-10T18:10:03.966Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06893211-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-07-07
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06893211-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06893211-tirzepatide-v1.json
- Content SHA-256: `a13dc73e237838f279d884b84b5772dc894c4f6d6358123baa9ccfdde565297b`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06893211 ([`ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d`](#source-ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06893211 at 2026-08-10T18:10:03.966Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d`](#source-ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06893211 at 2026-08-10T18:10:03.966Z. Its registry update date was 2026-07-07, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d`](#source-ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d`](#source-ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d))

## Sources

<a id="source-ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d"></a>
- **ClinicalTrials.gov record NCT06893211 · retained source version 2026-07-07:6ca8a3e5605da9a773bfdea0d6977dbd531d8d45e04e2e53d4049d717563d6f0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06893211) (`ctg-observation-nct06893211-2026-07-07-6ca8a3e5605d`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06893211." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06893211-tirzepatide-v1.json SHA-256: a13dc73e237838f279d884b84b5772dc894c4f6d6358123baa9ccfdde565297b.